Skip to content

Gross margin at other companies

Baxter International logo
Baxter InternationalBAX
30.1%-5.9pp
ADMA Biologics logo
ADMA BiologicsADMA
61.3%+8.7pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
62.3%+1.1pp
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
36.3%+1.7pp
Labcorp Holdings logo
Labcorp HoldingsLH
28.8%+0.9pp
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
97.8%+0.8pp

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s gross margin?
Lifecore Biomedical, Inc. (LFCR) reported gross margin of 31.3% in Q1 2025.
How has Lifecore Biomedical, Inc.'s gross margin changed year-over-year?
Lifecore Biomedical, Inc.'s gross margin decreased by 4.2% year-over-year, from 32.6% to 31.3%.
What is the long-term trend for Lifecore Biomedical, Inc.'s gross margin?
Over 4 years (2021 to 2025), Lifecore Biomedical, Inc.'s gross margin has grown at a -2.7% compound annual growth rate (CAGR), from 34.9% to 31.3%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.